135 related articles for article (PubMed ID: 30600764)
21. Evaluation of bone marrow as a metastatic site of human neuroblastoma.
Morandi F; Corrias MV; Pistoia V
Ann N Y Acad Sci; 2015 Jan; 1335():23-31. PubMed ID: 25315505
[TBL] [Abstract][Full Text] [Related]
22. Neuroblastoma: diagnostic imaging and staging.
Stark DD; Moss AA; Brasch RC; deLorimier AA; Albin AR; London DA; Gooding CA
Radiology; 1983 Jul; 148(1):101-5. PubMed ID: 6856817
[TBL] [Abstract][Full Text] [Related]
23. CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases.
Russell HV; Hicks J; Okcu MF; Nuchtern JG
J Pediatr Surg; 2004 Oct; 39(10):1506-11. PubMed ID: 15486895
[TBL] [Abstract][Full Text] [Related]
24. Bone scans in neuroblastoma.
Bhogate BM; Samuel AM; Ramanathan P
Indian J Cancer; 1993 Mar; 30(1):5-9. PubMed ID: 8500809
[TBL] [Abstract][Full Text] [Related]
25. Technetium-99m sestamibi imaging in paediatric neuroblastoma and ganglioneuroma and its relation to P-glycoprotein.
De Moerloose B; Van de Wiele C; Dhooge C; Philippé J; Speleman F; Benoit Y; Laureys G; Dierckx RA
Eur J Nucl Med; 1999 Apr; 26(4):396-403. PubMed ID: 10199946
[TBL] [Abstract][Full Text] [Related]
26. Clincal diagnosis: Metastatic liver tumors and bone marrow involvement of neuroblastoma.
Suga K
Ann Nucl Med; 2003 May; 17(3):254. PubMed ID: 12846550
[No Abstract] [Full Text] [Related]
27. Neuroblastoma and bone metastases: clinical significance and prognostic value of Dickkopf 1 plasma levels.
Granchi D; Corrias MV; Garaventa A; Baglìo SR; Cangemi G; Carlini B; Paolucci P; Giunti A; Baldini N
Bone; 2011 Jan; 48(1):152-9. PubMed ID: 20603237
[TBL] [Abstract][Full Text] [Related]
28. 131I-meta-iodobenzylguanidine in diagnosis and treatment of neuroblastoma.
Voûte PA; Hoefnagel CA; de Kraker J
Bull Cancer; 1988; 75(1):107-11. PubMed ID: 3359053
[TBL] [Abstract][Full Text] [Related]
29. Bone and bone marrow involvement in neuroblastoma: A case report.
Huang C; Jiang S; Liao X; Li Y; Li S; Yang J
Medicine (Baltimore); 2020 Oct; 99(40):e22505. PubMed ID: 33019449
[TBL] [Abstract][Full Text] [Related]
30. [[Role of bone marrow scintigraphy in defining the therapeutic approach for some malignant tumors in children] ].
Kanaev SV; Novikov SN; Zhukova LA; Malinin AP; Kolygin BA
Vopr Onkol; 2000; 46(4):419-22. PubMed ID: 11147416
[TBL] [Abstract][Full Text] [Related]
31. Imaging and treatment of disseminated neuroblastoma with 131I-meta-iodobenzylguanidine.
Gerrard M; Eden OB; Merrick MV
Br J Radiol; 1987 Apr; 60(712):393-5. PubMed ID: 3580745
[No Abstract] [Full Text] [Related]
32. Evaluating bone marrow metastasis of neuroblastoma with iodine-123-MIBG scintigraphy and MRI.
Lebtahi N; Gudinchet F; Nenadov-Beck M; Beck D; Bischof Delaloye A
J Nucl Med; 1997 Sep; 38(9):1389-92. PubMed ID: 9293795
[TBL] [Abstract][Full Text] [Related]
33. Neuroblastoma of unknown primary site with periorbital bone metastasis in a child.
Salmi D; Patel C; Imashuku S; Shimada H; Satake N
Pediatr Blood Cancer; 2010 Aug; 55(2):361-3. PubMed ID: 20582979
[TBL] [Abstract][Full Text] [Related]
34. Can MIBG scan replace the need for bone marrow assessment at diagnosis and reassessment in stage 4 neuroblastomas?
Frappaz D; Combaret V; Desuzinges C; Bouffet E; Bailly C; Favrot MC; Philip T
Bull Cancer; 2004; 91(7-8):E253-60. PubMed ID: 15381463
[TBL] [Abstract][Full Text] [Related]
35. Radionuclide bone scan in neuroblastoma.
Heisel MA; Miller JH; Reid BS; Siegel SE
Pediatrics; 1983 Feb; 71(2):206-9. PubMed ID: 6823421
[TBL] [Abstract][Full Text] [Related]
36. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Hematological Aspects between Neuroblastoma Patients with and without Bone Marrow Infiltration.
Wang W; Peng X; Liang C; Chen H; Zhang Y; Sun X; Shen L; Lu Y
Ann Clin Lab Sci; 2017 Aug; 47(4):416-421. PubMed ID: 28801367
[TBL] [Abstract][Full Text] [Related]
38. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases].
Lumbroso J; Guermazi F; Hartmann O; Coornaert S; Rabarison Y; Lemerle J; Parmentier C
Bull Cancer; 1988; 75(1):97-106. PubMed ID: 3359060
[TBL] [Abstract][Full Text] [Related]
39. A prospective comparison between magnetic resonance imaging, meta-iodobenzylguanidine scintigraphy and marrow histology/cytology in neuroblastoma.
Corbett R; Olliff J; Fairley N; Moyes J; Husband J; Pinkerton R; Carter R; Treleaven J; McElwain T; Meller S
Eur J Cancer; 1991; 27(12):1560-4. PubMed ID: 1782063
[TBL] [Abstract][Full Text] [Related]
40. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study.
Nickerson HJ; Matthay KK; Seeger RC; Brodeur GM; Shimada H; Perez C; Atkinson JB; Selch M; Gerbing RB; Stram DO; Lukens J
J Clin Oncol; 2000 Feb; 18(3):477-86. PubMed ID: 10653863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
